Exponent, Inc. (EXPO) Tops Q1 EPS by 16c

Exponent, Inc. (NASDAQ: EXPO) reported Q1 EPS of $0.58, $0.16 better than the analyst estimate of $0.42. Revenue for the quarter came in at $116.5 million versus the consensus estimate of $102.54 million.

Our business continued to gain momentum, driving strong quarterly results which exceeded our prior expectations. In the first quarter, net revenues grew 10% and EBITDA1 margin increased 400 basis points from the prior year period. These results were bolstered by increased activity in human participant studies and litigation projects. Exponent is winning new assignments daily, and at the same time is gradually reengaging on projects that were paused due to coronavirus restrictions and court closures,” commented Dr. Catherine Corrigan, President and Chief Executive Officer.

“The pandemic has altered many aspects of our lives, but one trend that has not abated is the growing complexity of our world. Exponent continues to leverage its expertise to understand and enhance human-machine interactions for technologies including wearables, medical devices and advanced vehicles. Exponent advises industry and governments on their most pressing engineering and scientific challenges as society continues to raise expectations for safety, health, sustainability and reliability. These long-term trends that existed prior to the pandemic are now only strengthening, driving increased demand for our services,” continued Dr. Corrigan

For earnings history and earnings-related data on Exponent, Inc. (EXPO) click here.

You May Also Be Interested In

• Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
• Preferred Bank (PFBC) Tops Q1 EPS by 6c
• SunPower (SPWR) determined prior financial statements should no longer be relied upon